Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma | NEJM – nejm.org October 21, 2023
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial – Bristol-Myers Squibb July 11, 2023
ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer – Yahoo Finance June 4, 2023
ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer – Yahoo Finance June 4, 2023
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial – AstraZeneca May 17, 2023
New breast cancer hope as AI breakthrough could spare THOUSANDS of women from chemotherapy October 9, 2022October 8, 2022
My Wife Of 52 Years Just Died. My Grief Is So Overwhelming, I Can Barely Cope. September 25, 2022September 25, 2022
Tumor-infiltrating lymphocytes therapy treats cancers at a large scale September 12, 2022September 12, 2022